-+ 0.00%
-+ 0.00%
-+ 0.00%
LB Pharma to host in-person, virtual R&D Day spotlighting LB-102 schizophrenia program
Share
Listen to the news
LB Pharma to host in-person, virtual R&D Day spotlighting LB-102 schizophrenia program
  • LB Pharmaceuticals will host an in-person and virtual R&D Day on Oct. 27, 2026, starting at 2:00 p.m. ET.
  • Program will highlight development of LB-102 in schizophrenia, ahead of a planned topline Phase 3 readout in H1 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060800PRIMZONEFULLFEED9839941) on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending